Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
CrossRef Anti-diabetic Drugs and Cancer: Integrated Mechanisms of Tumor Suppression and Clinical Translation Mahya Asadalizadeh, Mohammad Kazem Molavi Rahbar, Tabassom Mahmoudie, Mahshid Abbasi, Mitra Akbari, Davoud Shakiba, Aida Mohammadiun Shabestari, Meysam Ebrahimifar Indian Journal of Clinical Biochemistry.2026;[Epub] CrossRef Glucagon-like Peptide-1 receptor agonists are not associated with increased risk of pancreatic cancer: A systematic review and meta-analysis Gaetano Lauri, Paolo Giorgio Arcidiacono, Antonio Facciorusso, Gabriele Capurso, Matteo Tacelli Pancreatology.2026;[Epub] CrossRef GLP-1 Receptor Agonists: Therapeutic Potential and Emerging Concerns Klaudia Nowak, Krzysztof upina, Aleksandra Kalisz, ucja Ilkiewicz, Jakub Janczura Current Pharmacology Reports.2026;[Epub] CrossRef Optimizing glycemic control in oncology patients with diabetes mellitus S
References Therapeutic Goods Administration
BPC-157
.webp)
introduced the easy-albumin-bilirubin grade (easy-albumin-bilirubin) in 2020, which is much easier to calculate in estimating hepatic functional reserve and is strongly linked with the original ALBI grade (48)
US$ 29.00
US$ 26.60
US$ 28.57
US$ 29.61
US$ 28.22
US$ 28.56
.png)
